Tardive dyskinesia on clozapine treatment
Journal Article
2009
Permanent link to this Item
Authors
Journal Title
South African Journal of Psychiatry
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher
University of Cape Town
Faculty
License
Series
Abstract
Antipsychotic-induced tardive dyskinesia is a potentially irremediable and debilitating condition with the onset most commonly associated with the use of first-generation antipsychotics. The development of tardive dyskinesia on clozapine, a second-generation antipsychotic, is uncommon, and the drug is therefore a treatment option for those patients who develop the syndrome following treatment with first-generation agents. I report on the case of a 27-year-old man who developed severe tardive dyskinesia following initiation of clozapine treatment. To the best of my knowledge, this is the first case of tardive dyskinesia associated with clozapine use reported in South Africa.
Description
Reference:
Asmal, L. (2009). Tardive dyskinesia on clozapine treatment: case report. South African Journal of Psychiatry, 15(1), 23-24.